Pharma BD Deal Intelligence

Johnson & Johnson / Proteologix Inc.

2024 · Acquisition/Merger · $850M · Complete

Announcement Sentiment

88

Strongly positive

Outcome Score

66

Largely worked — most objectives met.

J&J acquired Proteologix for $850M for drug development.

Key facts

Announced May 16, 2024
Closed Jun 21, 2024
Deal value $850M
Deal type Acquisition/Merger
Therapeutic area Dermatology, Immunology

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals